After RIPCORD 2, FAME 3, FLOWER-MI and FUTURE: Has the Pressure Wire had its Day?

Recent years have seen the publication of several high-profile, negative trials about pressure wires. This has coincided with a consistent increase in the ratio of angioplasty for acute coronary syndromes versus percutaneous coronary intervention in stable coronary artery disease, a greater use of intracoronary imaging during percutaneous coronary intervention and the continued evolution of computational fluid dynamics-derived estimations of fractional flow reserve from both CT and invasive coronary angiography. Consequently, many interventional cardiologists now wonder if the pressure wire will soon become obsolete. This head-to-head article provides a critical appraisal of recent trial data, discusses a potential evolution in how pressure wires are used and debates the motion that the device (and by extension, invasive assessment of coronary physiology) has now had its day.

Informations de copyright

Copyright © The Author(s), 2024. Published by Radcliffe Group Ltd.

Déclaration de conflit d'intérêts

Disclosure: BM has received speaker/consultancy fees from Boston Scientific, Chiesi and Sanofi. DC has received speaker/consultancy fees from Abbott. All other authors have no conflicts of interest to declare. Authors’ contributions: Introduction: Ioannis Lampadakis, Sayan Sen; For: Bhavik Modi, Subhabrata Dutta; Against: Damien Collison